We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Teva Fights For Biaxin Marketing Rights

Law360 (April 19, 2007, 12:00 AM EDT) -- A protracted legal battle between Teva Pharmaceuticals USA and Abbott Laboratories took a new turn on Tuesday, with Teva filing a lawsuit seeking a declaratory judgment that its marketing of a generic version of Abbott’s extended-release antibiotic Biaxin is in line with a settlement the companies reached last August.

Teva said in court documents filed Tuesday in the U.S. District Court for the Southern District of New York that it filed the declaratory judgment action after counsel for Abbott told Teva attorneys that Abbott believes Teva’s...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.